Treat to target and REACT – Brian G Feagan MD
>> YOUR LINK HERE: ___ http://youtube.com/watch?v=22pGalTlsxc
REACT demonstrated the potential of early combined immunosuppression to change the natural course of Crohn’s disease; implementation challenges remain. • Watch more experts speak about treat to target in this special edition IBD Dialogue video series: http://goo.gl/kVO3ww • This is Issue 2 of a 12-part series. • Website: http://mentoringinibd.com/
#############################
![](http://youtor.org/essay_main.png)